august 2009 (18)
.
.
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
.
.
.
.
suven life sciences' pashamylaram facility successfully completes usfda inspection